STVN - When Will Stevanato's Free Cash Flow Turn Positive? This Analyst Has An Answer | Benzinga
Stephens analyst Jacob Johnson initiated coverage on Stevanato Group SPA (NYSE: STVN) at an Overweight rating with a price target of $33.
The analyst sees STVN as an industry leader in the glass containment solutions market and believes it benefits from growing biologics and injectables, driving demand for its solutions (including GLP-1s).
The analyst notes that the company targets a high single-digit growth rate to a low double-digit growth rate ...